Nitric Oxide Administration for Acute Respiratory Distress Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG

Nitric Oxide

Subjects will receive inhaled Nitric Oxide at a dose of 10 parts per million (ppm) for a 4 hour study period. Blood gases will be collected once an hour.

OTHER

No Intervention

Subjects will receive no intervention (i.e., no nitric oxide treatment) for a 4 hour study period. Blood gases will be collected once an hour. During this time, all subjects will receive standard clinical care.

Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER